Some patients with type 2 diabetes may benefit from intensive glycaemic and blood pressure control: A post-hoc machine learning analysis of ACCORD trial data.

Tianze JiaoHamed KianmehrYilu Lin Piaopiao LiNaykky Singh OspinaHans K GhayeeMohammed RuziehVivian A Fonseca Lizheng ShiPing ZhangStephen R Benoit

Published in: Diabetes, obesity & metabolism (2024)

Our findings suggest heterogeneous treatment effects of intensive glucose and BP control and could provide biomarkers for future clinical trials to identify more precise HbA1c and BP treatment goals for individualized medicine.

Keyphrases

clinical trial
blood pressure
machine learning
type diabetes
big data
metabolic syndrome
study protocol
phase iii
heart rate
blood glucose
public health
combination therapy
deep learning
open label